U.S. Swine Vaccines Market Size & Outlook, 2023-2030
U.S. swine vaccines market, 2018-2030 (US$M)
Related Markets
U.S. swine vaccines market highlights
- The U.S. swine vaccines market generated a revenue of USD 186.3 million in 2023 and is expected to reach USD 258.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 4.8% from 2024 to 2030.
- In terms of segment, inactivated (killed) was the largest revenue generating vaccine type in 2023.
- Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) is the most lucrative vaccine type segment registering the fastest growth during the forecast period.
Swine vaccines market data book summary
| Market revenue in 2023 | USD 186.3 million |
| Market revenue in 2030 | USD 258.7 million |
| Growth rate | 4.8% (CAGR from 2023 to 2030) |
| Largest segment | Inactivated (killed) |
| Fastest growing segment | Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Modified/ Attenuated Live, Inactivated (Killed), Other Vaccines (e.g. Recombinant, DNA, subunit, or toxoids) |
| Key market players worldwide | Merck & Co Inc, CEVA Inc, Zoetis, Boehringer Ingelheim, Elanco Animal Health Inc, Indian Immunologicals, Biogenesis Bago, Phibro Animal Health Corp Class A, Virbac SA |
Other key industry trends
- In terms of revenue, U.S. accounted for 11.3% of the global swine vaccines market in 2023.
- Country-wise, China is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. swine vaccines market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 29.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Swine Vaccines Market Scope
Swine Vaccines Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. swine vaccines market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to swine vaccines market will help companies and investors design strategic landscapes.
Inactivated (killed) was the largest segment with a revenue share of 39.94% in 2023. Horizon Databook has segmented the U.S. swine vaccines market based on modified/ attenuated live, inactivated (killed), other vaccines (e.g. recombinant, dna, subunit, or toxoids) covering the revenue growth of each sub-segment from 2018 to 2030.
The rising prevalence of different swine disorders, increasing pork consumption, and rising per capita animal healthcare spending are some of the factors expected to drive market growth in the U.S. For instance, the Agricultural Economic Insights (AEI) analysis found that meat consumption in the U.S. grew from 1970 to 2020.
In addition, an average American consumes 66.18 pounds of pork each year. According to Simmons National Consumer Survey and the U.S. Census Bureau statistics, about 268 million Americans ate bacon in 2020, with nearly 16 million consuming 5 pounds or more.
Furthermore, technological advancements in the vaccine sector and presence of established healthcare infrastructure in the country are expected to drive market growth. For instance, in September 2020, Pharm gate Animal Health introduced its new PRRS Gard, a recombinant chimeric vaccine, for Porcine Reproductive and Respiratory Syndrome (PRRS) that is primarily marketed in the U.S.
Reasons to subscribe to U.S. swine vaccines market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. swine vaccines market databook
-
Our clientele includes a mix of swine vaccines market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. swine vaccines market , including forecasts for subscribers. This country databook contains high-level insights into U.S. swine vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. swine vaccines market size, by vaccine type, 2018-2030 (US$M)
U.S. Swine Vaccines Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
